Clinical Trials in North Carolina

Showing 15781-15800 of 17,526 trials

Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline

NCT01400425

The study is designed to evaluate whether a florbetapir F 18 PET scan can impact clinical thinking when physicians are determining the likely cause of a subject's cognitive impairment.

Progressive Cognitive Decline

Avid Radiopharmaceuticals239 participantsStarted Jul 2011

Phoenix, Arizona, United States • Sun City, Arizona, United States • San Francisco, California, United States +15 more locations

COMPLETEDPhase 141 miles

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

NCT00003368

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may be effective in treating patients with abnormal liver or kidney function or who have received radiation therapy. PURPOSE: Phase I trial to study the effectiveness of irinotecan in treating patients with solid tumors or lymphoma who have abnormal liver or kidney function or who have had previous radiation therapy to the pelvis.

LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific

National Cancer Institute (NCI)Started Jun 1998

Birmingham, Alabama, United States • La Jolla, California, United States • San Francisco, California, United States +42 more locations

Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

Find Trials by Condition in North Carolina

A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease

A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy

Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients

The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting

Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa

Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer

Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma

Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage

MiDAS II (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and Adolescents

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Evaluation of Vitrase as a Spreading Agent

INFUSE® Bone Graft/ PEEK Interbody Spacer/ Anterior Cervical Plate Pivotal Clinical Trial

A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis

Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers

Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study